Variant of uncertain significance

Cost_per_Genome.png

Variant of Uncertain Significance (VUS) is a term used in genetics to describe a genetic variant whose association with disease risk is not yet established. This classification is often used in the context of genetic testing and genomic medicine.

Overview

A Variant of Uncertain Significance is a change in the DNA sequence that has been identified through genetic testing but whose impact on health and disease risk is not clearly understood. These variants are also sometimes referred to as "variants of unknown significance" or "variants of indeterminate significance."

Classification

Genetic variants are typically classified into five categories:

• Pathogenic
• Likely pathogenic
• Benign
• Likely benign
• Variant of Uncertain Significance

The classification of a VUS can change over time as more information becomes available through research and clinical studies.

Implications in Clinical Practice

The identification of a VUS can present challenges in clinical decision-making. Since the clinical significance of the variant is unknown, it can be difficult for healthcare providers to make informed recommendations regarding patient care and treatment options.

Management

When a VUS is identified, several steps may be taken to gather more information:

• Family studies to see if the variant segregates with the disease
• Functional studies to understand the biological impact of the variant
• Population studies to determine the frequency of the variant in different populations

Reclassification

Over time, a VUS may be reclassified as more data becomes available. This reclassification can move the variant into one of the other categories (pathogenic, likely pathogenic, benign, or likely benign), which can then inform clinical management.

Challenges

One of the main challenges with VUS is the psychological impact on patients and their families. The uncertainty can lead to anxiety and difficulty in making health-related decisions.

Future Directions

Advances in genomic research and the increasing availability of genetic databases are expected to improve the classification of VUS. Collaborative efforts among researchers, clinicians, and patients are essential for the reclassification of these variants.

See Also

• Genetic counseling
• Genetic testing
• Genomic medicine
• Pathogenic variant
• Benign variant